AbstractObjectives: The goal of this study was to determine whether there are differences in populations of patients with heart failure who require univentricular or biventricular circulatory support. (J Thorac Cardiovasc Surg 1997;113:202-9) Methods: Two hundred thirteen patients who were in imminent risk of dying before donor heart procurement and who received Thoratec left (LVAD) and right (RVAD) ventricular assist devices at 35 hospitals were divided into three groups: group 1 (n = 74), patients adequately supported with isolated LVADs; group 2 (n = 37), patients initially receiving an LVAD and later requiring an RVAD; and group 3 (n = 102), patients who received biventricular assistance (BiVAD) from the beginning. Results: There were n...
Objective—It is generally accepted that patients who require biventricular mechanical support (BiVAD...
OBJECTIVES: The purpose of this study was to describe pre- and postoperative data from the EUROMACS ...
AbstractObjective: The Thoratec ventricular assist device (Thoratec Laboratories, Pleasanton, Calif)...
AbstractObjectives: The goal of this study was to determine whether there are differences in populat...
Purpose: Biventricular support can be achieved using ventricular assist devices (BiVADs) or total ar...
Biventricular support can be achieved using ventricular assist devices (BiVADs) or total artificial ...
AbstractPatient selection is crucial for the success of ventricular assist devices as a bridge to he...
INTRODUCTION: There are conflicting reports on the posttransplantation morbidity and mortality of pa...
BACKGROUND: Although the left ventricular assist device (LVAD) has been increasingly used as a bridg...
AbstractWe have studied our experience since 1988 with 31 patients who required a mechanical circula...
OBJECTIVES: This study sought to determine the relationship between pre-transplant ventricular assis...
ObjectivesThis study sought to determine the relationship between pre-transplant ventricular assist ...
AimMechanical circulatory support is an alternative strategy as a bridge to transplantation for crit...
BACKGROUND: Patients requiring biventricular assist device (BiVAD) for mechanical circulatory suppor...
OBJECTIVE: For patients in advanced heart failure, emergency transplantation or ventricular assist d...
Objective—It is generally accepted that patients who require biventricular mechanical support (BiVAD...
OBJECTIVES: The purpose of this study was to describe pre- and postoperative data from the EUROMACS ...
AbstractObjective: The Thoratec ventricular assist device (Thoratec Laboratories, Pleasanton, Calif)...
AbstractObjectives: The goal of this study was to determine whether there are differences in populat...
Purpose: Biventricular support can be achieved using ventricular assist devices (BiVADs) or total ar...
Biventricular support can be achieved using ventricular assist devices (BiVADs) or total artificial ...
AbstractPatient selection is crucial for the success of ventricular assist devices as a bridge to he...
INTRODUCTION: There are conflicting reports on the posttransplantation morbidity and mortality of pa...
BACKGROUND: Although the left ventricular assist device (LVAD) has been increasingly used as a bridg...
AbstractWe have studied our experience since 1988 with 31 patients who required a mechanical circula...
OBJECTIVES: This study sought to determine the relationship between pre-transplant ventricular assis...
ObjectivesThis study sought to determine the relationship between pre-transplant ventricular assist ...
AimMechanical circulatory support is an alternative strategy as a bridge to transplantation for crit...
BACKGROUND: Patients requiring biventricular assist device (BiVAD) for mechanical circulatory suppor...
OBJECTIVE: For patients in advanced heart failure, emergency transplantation or ventricular assist d...
Objective—It is generally accepted that patients who require biventricular mechanical support (BiVAD...
OBJECTIVES: The purpose of this study was to describe pre- and postoperative data from the EUROMACS ...
AbstractObjective: The Thoratec ventricular assist device (Thoratec Laboratories, Pleasanton, Calif)...